We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
When faced with drug shortages or supply chain issues affecting a branded drug product, generic drug manufacturers need to move quickly to help ensure that needed therapies reach the market safely and efficiently. Access to high-quality packaging and delivery components can make a huge difference in ensuring patients receive life-saving medications on schedule.
At West, we work by the side of our generic drug partners to ensure that they have access to components that not only meet the increasing demand for better quality packaging and delivery for generic drug products, but also provide the efficiencies they need to make the move to market fast.
Speed to market is also important for generic customers who may hold a number of Abbreviated New Drug Applications (ANDAs ) and need to move quickly to produce different products in their portfolio, which can be driven by market conditions such as drug shortages where there is a need to respond immediately.
Our AccelTRA® component program provides a robust, efficient platform of components that are compatible with a broad variety of generics molecules and chemicals. This program offers customers the possibility of building a platform of delivery options and packaging for a variety of molecules with a single supply platform.
In addition, West has built a global supply chain network to provide made-to-stock AccelTRA components with extremely fast sampling and delivery lead times. Samples are available with a one-week lead time, and commercial quantities within six weeks.
At West, we’re by your side with excellent technical service that helps customers work through issues and make the move to market fast. We bring the service solutions – including laboratory services, contract manufacturing, and regulatory support for a growing number of proprietary delivery devices – so that customers that need to move fast have the services available to help.Click the links for more information about our AccelTRA program, or our Integrated Solutions (link) program.
AccelTRA® is a registered trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
West is pleased to announce that the AccelTRA™ component program has been recognized with a 2018 India Packaging Award in the category of “Packaging Design in Injectables.” The award was announced during a ceremony at the 2018 InnoPack Pharma Confex in Mumbai, India on May 24, 2018.
Recently, the generics pharmaceutical industry in the United States has seen the average time to market decrease significantly as approvals have steadily increased thanks to the introduction of the Generic Drug User Fee Amendments (GDUFA) in October 2012. The reduction in time has led pharmaceutical companies to seek out high-quality elastomer products that provide the regulatory simplicity necessary to bring their products to market quickly, helping to increase a company’s competitiveness and their drug product’s overall sales. The AccelTRA™ elastomer program is built on these features: Quality, Speed, Simplicity.<br />
For any drug, selection of the appropriate primary packaging components is essential to having a containment system that ensures quality, safety, and stability. The primary packaging components are selected based on various factors, which include chemical compatibility with the drug product ingredients and dimensional fit with mating packaging components. Optimized fit among mating packaging components is essential for flawless fill-finish processing.
To meet the ever-increasing demand of growing domestic pharmaceutical markets, the AccelTRA<sup>®</sup> Components Program has expanded to include an RTS/RTU product line with Ready-to-Sterilize (RTS) and Ready-to-Use (RTU) gamma sterilized stoppers developed to provide an innovative customer service package to help customers get their products to market quickly.
At the recent CPhI China Conference, we introduced our Integrated Solutions Program to the Asia Pacific Market. The Program is designed to help reduce risk, mitigate regulatory complexity and Simplify the Journey™ from molecule to market for our pharmaceutical partners.
English
Chinese
